Cardiac doses with deep inspiration breath hold in breast cancer radiotherapy: direct comparison between WBI, PBI, and interstitial APBI.

brachytherapy cardiac doses left breast irradiation

Journal

Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
ISSN: 1507-1367
Titre abrégé: Rep Pract Oncol Radiother
Pays: Poland
ID NLM: 100885761

Informations de publication

Date de publication:
2024
Historique:
medline: 15 8 2024
pubmed: 15 8 2024
entrez: 15 8 2024
Statut: epublish

Résumé

The optimal radiotherapy technique for cardiac sparing in left-sided early breast cancer (EBC) is not clear. In this context, the aim of our dosimetric study was to compare cardiac and lung doses according to the type of radiotherapy - whole breast irradiation (WBI), external partial breast irradiation (PBI), and multicatheter interstitial brachytherapy-accelerated partial breast irradiation (MIB-APBI). The dosimetric results with the WBI and PBI were calculated with and without DIBH. Dosimetric study of 23 patients treated with WBI, PBI, with and without DIBH, or MIB-APBI. The prescribed dose was 40 Gy in 15 fractions for WBI and PBI and 34 Gy in 10 fractions (bid) for MIB-APBI. Doses to the organs-at-risk (OAR) - heart, left anterior descending coronary artery (LAD), left ventricle (LV), and left lung - were recalculated to the equivalent dose in 2-Gy fractions (EQD2). The addition of DIBH significantly reduced EQD2 doses to all OARs (except for the left lung maximal dose) in WBI and PBI. MHD values were 0.72 Gy for DIBH-WBI, 1.01 Gy for MIB-APBI and 0.24 Gy for DIBH-PBI. There were no significant differences in cardiac doses between WBI with DIBH and PBI without DIBH. DIBH-PBI resulted in significantly lower mean doses to all OARs (except for maximum lung dose) compared to MIB-APBI. Conclusions: These results show that the use of DIBH significantly reduces cardiac doses in patients with left EBC. Partial irradiation techniques (PBI, MIB-APBI) significantly reduced cardiac doses due to the smaller clinical target volume. The best results were obtained with DIBH-PBI.

Sections du résumé

Background UNASSIGNED
The optimal radiotherapy technique for cardiac sparing in left-sided early breast cancer (EBC) is not clear. In this context, the aim of our dosimetric study was to compare cardiac and lung doses according to the type of radiotherapy - whole breast irradiation (WBI), external partial breast irradiation (PBI), and multicatheter interstitial brachytherapy-accelerated partial breast irradiation (MIB-APBI). The dosimetric results with the WBI and PBI were calculated with and without DIBH.
Materials and methods UNASSIGNED
Dosimetric study of 23 patients treated with WBI, PBI, with and without DIBH, or MIB-APBI. The prescribed dose was 40 Gy in 15 fractions for WBI and PBI and 34 Gy in 10 fractions (bid) for MIB-APBI. Doses to the organs-at-risk (OAR) - heart, left anterior descending coronary artery (LAD), left ventricle (LV), and left lung - were recalculated to the equivalent dose in 2-Gy fractions (EQD2).
Results UNASSIGNED
The addition of DIBH significantly reduced EQD2 doses to all OARs (except for the left lung maximal dose) in WBI and PBI. MHD values were 0.72 Gy for DIBH-WBI, 1.01 Gy for MIB-APBI and 0.24 Gy for DIBH-PBI. There were no significant differences in cardiac doses between WBI with DIBH and PBI without DIBH. DIBH-PBI resulted in significantly lower mean doses to all OARs (except for maximum lung dose) compared to MIB-APBI. Conclusions: These results show that the use of DIBH significantly reduces cardiac doses in patients with left EBC. Partial irradiation techniques (PBI, MIB-APBI) significantly reduced cardiac doses due to the smaller clinical target volume. The best results were obtained with DIBH-PBI.

Identifiants

pubmed: 39143972
doi: 10.5603/rpor.99907
pii: rpor-29-2-155
pmc: PMC11321770
doi:

Types de publication

Journal Article

Langues

eng

Pagination

155-163

Informations de copyright

© 2024 Greater Poland Cancer Centre.

Déclaration de conflit d'intérêts

Conflict of interests: Authors declare no conflict of interests.

Auteurs

Igor Sirak (I)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Denisa Pohanková (D)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Linda Kašaová (L)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Miroslav Hodek (M)

Clinic of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
4 Department of Internal Medicine - Hematology, University Hospital Hradec Kralove, Charles University Faculty of Medicine in Hradec Králové, Hradec Kralove, Czech Republic.

Petr Motyčka (P)

Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Ahmed Asqar (A)

Department of Surgery, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.

Jakub Grepl (J)

Department of Radiotherapy and Oncology, University Hospital Hradec Kralove, Hradec Kralove, Czech Republic.
Department of Radiobiology, University of Defence in Brno, Brno, Czech Republic.

Petr Paluska (P)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Veronika Novotná (V)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Milan Vosmik (M)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Jiri Petera (J)

Department of Oncology and Radiotherapy, University Hospital Hradec Kralove, Hradec Králové, Czech Republic.

Classifications MeSH